Compounds > fluorescein-5-isothiocyanate
Page last updated: 2024-08-22

fluorescein-5-isothiocyanate and Minimal Disease, Residual

fluorescein-5-isothiocyanate has been researched along with Minimal Disease, Residual in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coupek, P; Doubek, M; Klabusay, M; Pevna, M; Stehlikova, O1
Ding, C; Fan, J; Guan, Z; Liu, L; Wang, L; Wang, R; Wang, W; Wang, X; Wu, K1
Gottlieb, DJ; Sartor, MM1
Campana, D; Coustan-Smith, E; De Propris, MS; Foà, R; Guarini, A; Krampera, M; Pasini, A; Perbellini, O; Pizzolo, G; Scupoli, MT; Vincenzi, C; Zampieri, F1
Ambros, IM; Ambros, PF; Gadner, H; Hattinger, CM; Lörch, T; Luegmayr, A; Méhes, G1

Other Studies

5 other study(ies) available for fluorescein-5-isothiocyanate and Minimal Disease, Residual

ArticleYear
Residual cancer lymphocytes in patients with chronic lymphocytic leukemia after therapy show increased expression of surface antigen CD52 detected using quantitative fluorescence cytometry.
    Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Calibration; CD52 Antigen; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fluorometry; Glycoproteins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm, Residual; Patient Selection; Remission Induction

2014
Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
    Oncotarget, 2017, Jan-17, Volume: 8, Issue:3

    Topics: Cell Line, Tumor; Cell-Penetrating Peptides; Contrast Media; Dose-Response Relationship, Drug; Ferric Compounds; Fluorescein-5-isothiocyanate; Humans; Lysosomes; Magnetic Resonance Imaging; Magnetite Nanoparticles; Neoplasm, Residual; Oligopeptides; Urinary Bladder Neoplasms

2017
A single tube 10-color flow cytometry assay optimizes detection of minimal residual disease in chronic lymphocytic leukemia.
    Cytometry. Part B, Clinical cytometry, 2013, Volume: 84, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Color; Cyclophosphamide; Disease-Free Survival; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Rituximab

2013
Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia.
    Haematologica, 2006, Volume: 91, Issue:8

    Topics: Adult; Antibodies, Monoclonal; Antigens, CD; B-Lymphocytes; Bone Marrow Cells; Burkitt Lymphoma; Child; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Neoplasm, Residual; Reference Values; Regeneration

2006
Automatic detection and genetic profiling of disseminated neuroblastoma cells.
    Medical and pediatric oncology, 2001, Volume: 36, Issue:1

    Topics: Biomarkers, Tumor; Blood Cell Count; Bone Marrow Examination; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 17; Diagnosis, Computer-Assisted; DNA Probes; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Gangliosides; Gene Amplification; Gene Expression Profiling; Genes, myc; Humans; In Situ Hybridization, Fluorescence; Indoles; Neoplasm, Residual; Neoplastic Cells, Circulating; Neuroblastoma; Sensitivity and Specificity; Trisomy; Tumor Cells, Cultured

2001